Form 8-K - Current report:
SEC Accession No. 0001213900-21-009271
Filing Date
2021-02-16
Accepted
2021-02-16 08:37:32
Documents
3
Period of Report
2021-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea135721-8k_wizepharma.htm 8-K 21705
2 PRESS RELEASE, DATED FEBRUARY 16, 2021: WIZE PHARMA'S TAKEOVER OFFER FOR COSMOS ea135721ex99-1_wizepharma.htm EX-99.1 16814
3 GRAPHIC ex99-1_001.jpg GRAPHIC 7537
  Complete submission text file 0001213900-21-009271.txt   50308
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 21632881
SIC: 2834 Pharmaceutical Preparations